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Skeletal muscle fatigue has a complex multifaceted etiology in which the ability to regulate 
intracellular calcium concentration ([Ca
2+
]i) and the myofibrillar response to elevated [Ca
2+
]i are 
key components. Pertinent to this issue, a calcium sensitizer compound has been shown to increase 
contractile function via altered myofibrillar Ca
2+
sensitivity in in-vitro preparations.  We tested the 
hypothesis that a calcium sensitizer compound would increase the endurance capacity and VO2peak 
in young male Sprague-Dawley rats above saline control values. The exercise tolerance test 
consisted of a progressive exercise test in which each rat initially ran at a speed of 25 m/min up a 
10% grade for 15 min. Thereafter the treadmill speed was increased by 5m/min every 15 min until 
fatigue (i.e., the rat could no longer maintain pace with the treadmill). VO2peak was determined 
according to previously established methods used in our laboratory. Each rat initially ran at 25 
m/min up a 10% grade for 2-3 minutes. The speed of the treadmill was the increased 
progressively in a ramp-like manner until fatigue. VO2peak was defined either as the point at 
which O2 uptake did not further increase despite increases in treadmill speed or the highest 
VO2peak prior to fatigue. A calcium sensitizing compound or saline was administered via gastric 
gavage. There was a significant increase (P<0.05) in endurance capacity with 10 mg/kg of the 
calcium sensitizer compound, but not at lower (0.5-5 mg/kg) or higher (20-40mg/kg) doses. This 
improvement in endurance capacity occurred in the absence of any changes in VO2peak.  The 
highest dose (40 mg/kg) produced a significant decrease (P<0.05) in the endurance capacity as 
well as VO2peak. These data demonstrate that the in-vitro observations of increased [Ca
2+
]i 
sensitivity and improved muscle function with a calcium sensitizing compound can translate to 
improved whole body exercise performance. Further studies need to be conducted to explore the 
efficacy of calcium sensitizing agents in animal models of chronic disease (i.e. CHF and 
diabetes). It is possible that a calcium sensitizer compound could be used as a potential ergogenic 
aid for patients whom enhanced physical capacity could be of significant therapeutic value, and 
lead to increases in activities of daily living and quality of life.
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CHAPTER 1 - INTRODUCTION 
 
 
Repeated, intense muscle contraction(s) leads to a decline in performance known as 
muscle fatigue. This phenomenon is reversible after a period of rest (Eberstein and Sandow, 
1963; Allen et al., 2008). There have been multiple mechanisms identified that may contribute 
to muscle fatigue. These include changes in the action potential, altered regulation of 
extracellular and intracellular ions, and intracellular metabolites, as well as a reduction of force 
and shortening velocity, and/or prolongation of muscle relaxation (Allen et al., 2008; Allen et 
al., 1995). 
Muscles are activated by a complex pathway originating in the motor cortex that leads to 
excitation of the lower motor neurons in the spinal cord. From there, the axon of the lower motor 
neuron carries the action potential (AP) to the neuromuscular junction of the muscle. The action 
potential in the motor neuron causes the release of acetylcholine (Ach) into the synaptic cleft of 
the neuromuscular junction. Ach binds with receptors on the motor end-plate, producing an end-
plate potential that leads to AP conduction down the transverse tubules (t-tubules). When the AP 
reaches the voltage gated calcium Ca
2+
 channels which connect with the sarcoplasmic reticulum 
(SR), Ca
2+
 is released into the sarcoplasm. The Ca 
2+
 binds to troponin which causes a shift of 
tropomyosin to uncover the “active sites” located on actin. Following this, Adenosine 
Triphosphate (ATP) is broken down to adenosine diphosphate (ADP) + inorganic phosphate (Pi) 
+ energy and the released energy is used to “cock” the myosin crossbridge. Then the “cocked” 
myosin crossbridge attaches to the active site on actin and pulls the actin molecule over the 
myosin. Next, the attachment of “fresh” ATP to the myosin crossbridge allows the crossbridge to 
detach from actin and the contraction cycle is repeated as long as Ca
2+
 (and ATP) is present. 
Finally the AP stops, the SR actively removes Ca
2+
 from the sarcoplasm and tropomyosin moves 
to its inhibitory position covering the active sites on the actin molecules. This process 
emphasizes the importance of Ca
2+
 in skeletal muscle contraction/relaxation. 
 
The processes that occur inside the spinal cord and within higher neural pathways are 
generally defined as central, whereas the processes in the peripheral nerve, neuromuscular 
junction, and muscle are defined as peripheral in function (Allen et al., 2008). It is clear that 
fatigue can potentially arise at one or more points throughout this pathway, and as such can be 
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classified as central fatigue and/or peripheral fatigue. Some studies suggest that some degree of 
fatigue is due to central failure of activation (Noakes & Tucker, 2008; Marcora, 2008; Gandevia, 
2001). However, the compelling weight of evidence indicates that fatigue arises primarily from 
within the muscles (peripheral), and therefore can be studied via either isolated muscle tissues or 
during whole body exercise (Allen et al., 2008). 
As discussed by Allen & Westerblad (1995) the reduction in isometric force can be 
divided into three components: (1) reduced maximum isometric force (i.e. force at saturating 
calcium concentration, Fmax); (2) reduced myofibrillar Ca
2+
 sensitivity; and (3) reduced SR 
Ca
2+
 release, causing a decline in myoplasmic free calcium concentration ([Ca
2+
]) during the 
tetanus (tetanic [Ca
2+
]i). One study concluded that fatigue caused by voluntary repeated short 
tetani in a human can lead to a 50% reduction in force production. (Bigland-Ritchie et al., 
1986). Of that 50% decline, it’s suggested that ~10% is due to reductions in Fmax due to 
increased Pi, and the remaining 40% is attributed to decreased Ca
2+
 sensitivity of contractile 
proteins and reduced sarcoplasmic reticulum (SR) release (Allen et al., 2008). 
 
Thus, a calcium sensitizing compound that may up regulate Ca
2+
 sensitivity of skeletal 
muscle may prevent or constrain the decreased contractile performance of contracting muscle(s). 
Pursuant to this issue, there are many studies that have shown that reduced tetanic [Ca
2+
]i is an 
important factor for the force decline in fatigue (Allen et al., 1989; Westerblad & Allen, 1991; 
Westerblad & Allen, 1993). It is possible that a calcium sensitizing compound may work like 
other agents capable of facilitating and increased Ca
2+
 sensitivity and SR Ca
2+
 release, such as 
caffeine, by sensitizing the Ryanodine receptor (RYR) channels to activation of cystolic [Ca
2+
], 
leading to an increase in the open probability (Po) of the channel (Eberstein and Sandow, 1963). 
 
Pertinent to this issue, increased fatigability is a common accompaniment to many 
different disease states (such as CHF and diabetes) that affect skeletal muscle. Understanding the 
mechanisms involved with the structural and functional maladaptations of these diseases may 
help to cure or, at least, alleviate some of the symptoms associated with them, such as exercise 
intolerance. 
 
The purpose of this present investigation was to test, non-invasively, if a calcium 
sensitizing compound affects exercise performance and peak oxygen uptake (VO2peak) in male 
Sprague-Dawley rats. This study was designed to test the in-vivo efficacy of a calcium 
sensitizing compound in healthy animals as an essential precursor to evaluating its utility in the  
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treatment of chronic diseases such as CHF.  We tested the hypothesis that the rats’ demonstrated 
ability to generate more force in their locomotor muscles will translate into: 
1) The ability to exercise at a greater maximal workload and use more O2 (VO2peak) 


























































CHAPTER 2 - Review of Literature 
 
 
The mechanisms of skeletal muscle fatigue have been studied for many years. Eberstein 
and Sandow (1963) first suggested that failure of excitation-contraction (EC) coupling 
contributed to muscle fatigue. The literature suggests that an array of mechanisms are involved 
with skeletal muscle fatigue. The challenge is to determine which mechanisms contribute to 
skeletal muscle fatigue under different circumstances. The majority of the mechanistic studies of 
fatigue have been performed in-vitro on isolated animal tissues. One important challenge is for 
scientists to take the knowledge generated from these studies, and place it within the context of 
fatigue in intact animals particularly during whole body exercise to help understand the etiology 
of exercise intolerance that is symptomatic of chronic human disease(s). 
 
1) Excitation-Contraction Coupling in Skeletal Muscle 
 
Excitation-contraction (EC) coupling in skeletal muscle is well understood (Dulhunty, 
2006; Melzer et al., 1995; Stephenson et al., 1998). Failure in one of the processes associated 
with EC coupling could contribute to fatigue. The AP of the muscle begins at the neuromuscular 
junction by release of Ach. The transmission of the AP along the surface membrane is dependent 
on the sodium (Na
+
) channels. Potentially, AP transmission could be influenced by numerous 
factors including the membrane potential, the extracellular and intracellular Na
+
 and Potassium 
(K
+
) concentrations, the internal and external resistances, or the membrane resistance and 
capacitance (Allen et al., 2008). From the myocyte surface, the AP is conducted down the t-
tubules into the interior of the muscle (Bezanilla et al., 1972). The t-tubule has a high content of 
L-type Ca
2+
 channels which change their conformation during an AP, resulting in a charge 
movement. These voltage sensitive channels are in close contact with SR Ca
2+
 release channels, 
and lead to conformational change in the ryanodine (RYR) receptor and opening of the SR Ca
2+
 
release channel (Schmeider & Chandler, 1973). SR Ca2+ release fails in many types of fatigue, 




 released from the SR gives rise to a transient increase in myoplasmic free Ca
2+
. 
This calcium binds to troponin C and instigates the movement of tropomyosin, which allows for 





 concentration depends on the coordinated activity of SR Ca
2+
 release, 
troponin C, parvalbumin, the SR Ca
2+
 pump, calmodulin, and ATP, which are calcium buffers 
(Baylor & Hallingsworth, 1998). Currently there are no measurements of Ca
2+
 buffering in 
muscle fatigue which could assess how the Ca
2+
 buffering is affected by the ionic and 
metabolic changes associated with fatigue; as a consequence, the assumption that changes in the 
Ca
2+
 transient reflect changes in SR Ca
2+
 release may be incorrect. 
 
E-C coupling concludes with cross-bridge activation and the muscle relaxes as Ca
2+
 is 
pumped back into the SR by an ATP-driven SR Ca
2+
 pump, decreasing cytosolic or myoplasmic 
[Ca
2+
]. These SR pumps are sensitive to many of the metabolic changes that are associated with 
fatigue such as changes in [ATP], [ADP], and/or magnesium concentrations [Mg
2+
], however 
the contribution of the changing pump properties to the slowing of relaxation in fatigue are still 
uncertain (Allen et al., 2008). 
 
2) Role of Inorganic Phosphate (Pi) in Skeletal Muscle Fatigue 
 
The exchange of high energy phosphate between ATP and Phospho creatine (PCr) is 
catalyzed by creatine kinase (CK) according to the following reaction: PCr + ADP + H
+
 → Cr 
(creatine) + ATP. During times of high energy demand, the ATP concentration remains constant 
while PCr breaks down into Cr and diprotonated Pi (Allen et al., 2008). This Pi may cause a 
decrease of myofibrillar force production and reduced Ca
2+
 sensitivity as well as impaired SR 
Ca
2+
 release. Increased Pi is considered to be a major cause of fatigue (Westerblad et al., 2002). 
This has been shown in mice lacking creatine kinase in their skeletal muscles (CK 
-/-
 mice). 
Fast-twitch skeletal muscle fibers of CK
-/ -
 mice display an increased myoplasmic Pi 
concentration at rest; furthermore, during fatigue there is no significant Pi accumulation. The 
maximum Ca
2+
 -activated force of unfatigued CK
-/-
 fast-twitch fibers is markedly lower than 
that of wild-type fibers, which supports a force-depressing role of increased Pi (Dahlstedt et al., 
2001). 
 
The current models of cross-bridge force production state that the myosin head is first 
bound weakly and then strongly to the actin filament (Allen et al., 2008). Thereafter Pi is 
released, possibly resulting in a further decrease in force production (Takagi et al., 2004). This 
would imply that the transition to a high-force cross-bridge attachment is inhibited by increased 
Pi and fewer cross bridges would be in the high-force state when Pi increases during fatigue 
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mainly due to the breakdown of PCr. The effect of Pi on cross-bridge force production has 
proven difficult to test directly in intact muscle cells because altering myoplasmic Pi directly 
produces other metabolic changes. Again, the most recent experimental model that has been 










display an increased myoplasmic Pi concentration at rest, and there is no significant Pi 
accumulation during fatigue. The Fca,max (tetanic Ca
2+





fast-twitch fibers is markedly lower than that of normal wild type fibers, and this can be partly 
explained by a Pi-induced depression of cross-bridge force production (Steeghs et al., 1997). In 
conclusion, increased myoplasmic Pi can inhibit force production by direct action on the cross-
bridge, and is likely responsible for the decrease in tetanic force. 
 
3) Lactate and H
+
 and Their Roles in Skeletal Muscle fatigue 
 
Historically, the accumulation of lactic acid in muscle has been considered a major 
cause of muscle fatigue (Fitts, 1994). Lactate and H
+
 are produced by the muscle during heavy 
intense exercise, and, in humans, the intracellular lactate concentration may reach 30mM or 
more, driving the intracellular pH down by ~ 0.5pH units (Sahlin et al., 1976). Although 
increased levels of lactate may reduce muscle performance (Hogan et al., 1995), it appears that 
its harmful effects have been considerably overestimated and that other beneficial effects have 
been overlooked (Westerblad et al., 1997). 
 
Experiments with skinned muscle fibers at constant ionic strength have shown that 
lactate concentrations up to 50mM have a relatively modest effect on force production by the 
contractile machinery, reducing maximum force (Fmax) by < 5% and having little or no effect on 
Ca
2+
 sensitivity. Also, skinned fiber experiments with functional excitation contraction E-C 
coupling have shown that voltage-sensitive activation of Ca
2+
 release is little, if at all, affected 
and twitch and tetanic forces are virtually unchanged in the presence of 30mM lactate 
concentration ( [La
-
]) (Andrews et al., 1996; Chase & Kushmerick, 1988; Posterino & Lamb, 
2003). The research largely suggests that the intracellular accumulation of lactate is not the 
major factor in muscle fatigue (Hogan et al., 1995). 
 
Skeletal muscle pH at rest is ~ 7.05 and after exhaustive exercise may drop to as low as ~ 
6.5 (Sahlin et al., 1976; Spriet et al., 1989). However, in other cases, pH decreases only 
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to 6.8 or 6.9 at the point of exhaustion (Bangsbo et al., 1996; Hogan et al., 1999). These results 
demonstrate that muscle fatigue can occur without large changes in hydrogen ion concentrations 
([H
+
]). At the onset of exercise or muscle stimulation, pH may initially increase due to the H
+
 
consumed during PCr breakdown, and conversely, pH can decrease as PCr is resynthesized 
(Sahlin & Ren, 1989). Studies have shown that when pH does drop to low levels in a fatigued 
muscle, upon ceasing the exercise or stimulation, force typically recovers much faster than pH, 
indicating that the low pH per se was not responsible for the force production deficit (Baker et 
al., 1993; Cady et al., 1989; Sahlin & Ren, 1989; Thompson et al., 1992). Furthermore, 
attenuating the decline in muscle pH during a stimulation period does not reduce fatigue in frog 
muscle fibers (Stary & Hogan, 2005). 
 
It is pertinent that low pH also reduces Ca
2+
 sensitivity of the contractile machinery 
(Fabiato & Fabiato, 1978) likely due to the H
+
 competing with Ca
2+
 binding to troponin C. This 
is often presumed to have major deleterious effects on muscle performance. However, low pH 
may also reduce the affinity of Ca
2+
 binding at other sites in the muscle fiber, in particular that 
of the SR Ca
2+
 pump which may lead to an increase in resting cytoplasmic free Ca
2+
 
(Westerblad et al., 1993) which may actually favor and increase in force development. Thus, 
even though the affinity of troponin C for Ca
2+
 may be reduced, the total amount of Ca
2+
 
binding to troponin C may not decrease (Allen et al., 2008). In summary, it is now considered 
that low pH has far less severe inhibitory effects on the activation of the contractile machinery 
and Ca
2+
 release than previously suggested, and its affects on the SR Ca
2+
 pump may actually 




3) Role of Reactive Oxygen Species 
 
Within the scientific community, the interest in reactive oxygen species (ROS) 
has grown rapidly. There is strong evidence that ROS play a role in skeletal muscle fatigue. For 
example, exogenous ROS scavengers (such as N-acetylcysteine, superoxide dismutase (SOD), 
dimethyl sulfoxide (DMSO), catalase, Tempol) reduce the rate of fatigue in isolated muscles, 
intact animals, and in humans (Shindoh et al., 1990; Reid et al., 1992; Moopanar & Allen, 2005). 
The most important ROS are superoxide (O2
-
), hydrogen peroxide (H2O2), and hydroxyl radicals 
(OH
-
). In addition nitric oxide (NO) can interact with O2
-
 to form peroxynitrate (ONOO
-




many reactive nitrogen species that likely have a role in skeletal muscle fatigue (Reid & Durham, 
2002). 
The increase in ROS during exercise or muscle stimulation is well established, but 
the source of ROS is not as well understood. Mitochondria are generally thought to be the main 
source of ROS because of the direct production of O2
-
, especially during intense exercise when 
mitochondrial O2 consumption increases up to 100-fold. It is thought that the excess O2
-
 may 
form H2O2 and diffuse across the mitochondrial membrane into the myoplasm (Clanton et al., 
1999). Another possible source of ROS is nonphagocytic NAD(P)H oxidase (NOX). The current 
literature suggests that NOX may be associated with the SR or t-tubular membrane (Xia et al., 
2003; Hidalgo et al., 2006; Javesghani et al., 2002). These studies showed NOX-dependent O2
-
 
production, and inhibitors of NOX (diphenyleneiodonium, DPI) reduced O2 
-
 production by the 
muscle. Currently there is no consensus about the major source of ROS production within the 
muscle, but mitochondria and NOX seem probable contenders. 
 
ROS such as O2
-
 and H2O2, may decrease maximum Ca
2+
 activated force 
(Andrade et al., 1998; Plant et al., 2001). Specifically, O2
-
 causes a 15% reduction in Fca,max, and 
hydroxyl radicals reduce force by 44%. ROS may also decrease Ca
2+
 sensitivity (Andrade et al., 
2001; Andrade et al., 1998). One study showed that longer exposure to large concentrations of 
H2O2 causes a large fall in Ca
2+
 sensitivity that is reversed by dithioreitol (DTT) which is a 
membrane-permeant thiol-specific reducing agent capable of converting disulphide bridges in 
proteins to sulphydryl groups. Interestingly, the administration of DTT caused a decrease in 
Ca
2+
 sensitivity when applied alone, suggesting alterations in the ROS-sensitive signaling 
pathway (Allen et al., 2008). Lastly, it has also been established that ROS can inhibit the SR 
Ca
2+
- ATPase and reduce the rate of Ca
2+
 re-uptake into the SR which has negative effects on 
skeletal muscle force production, and may contribute to muscle fatigue. (Scherer & Deamer, 
1986). 
 
It is clear that ROS are generated in active muscle and contribute to the process 
of fatigue. How ROS are produced and which ROS play a major role in skeletal muscle fatigue 










 Content and Its Role in Fatigue 
 
The total amount of Ca
2+
 contained and released within muscle fiber is important 
to its overall function. In resting rat skeletal muscle, the total Ca
2+
 content in both fast- and 
slow- twitch fibers is ~ 1.1 mmol/kg, with most of this stored in the SR, equivalent to about 11 
(fast) and 21 (slow) mM when expressed relative to the respective SR volume (Fryer & 
Stephenson, 1996; Gissel & Clausen, 1999; Owen et al., 1997). Total Ca
2+
 in human muscle 
fibers is slightly lower (about 0.8 mmol/kg) (Overgaard et al., 2004; Salviati et al., 1982). The 
majority of the Ca
2+
 in the SR is bound to calsequestrin. If the total number of Ca
2+
 molecules 
in the SR drops substantially below its normal level, the amount of Ca
2+
 released by each action 
potential is reduced, thus reducing the force response (Posterino & Lamb, 2003). Specifically a 
35% decrease in the SR Ca
2+
 content reduces peak tetanic force by 46% (Dutka et al., 2005). 
This occurs despite the fact that the amount of Ca
2+
 remaining in the SR may be considerably 
higher than the number of Ca
2+
 binding sites on troponin C. Thus it is the reduction in the total 
amount of releasable Ca
2+
 in the SR that adversely affects Ca
2+
 release and impairs the force 
responses. 
 
5) Slowing of Relaxation 
 
Skeletal muscle fatigue is accompanied by a marked slowing of relaxation. This slowing 
of relaxation can limit performance during dynamic exercise where rapidly alternating 
movements are performed (Allen et al., 1995). Relaxation of skeletal muscle cells is a complex 
process that involves the following steps: 1) SR Ca
2+
 release stops, 2) Ca
2+
 is taken up by the 
SR via ATP- driven pumps, 3) the resulting decline in [Ca
2+
] means that Ca
2+
 dissociates from 
troponin C, and 4) cross bridge cycling ceases. Potentially, any disturbance in these steps could 
contribute to the slowing of relaxation. The changes in ADP and Pi during fatigue directly affect 
myosin and SR Ca
2+





It is widely accepted that fatigue has a complex and a multi- focal etiology and that in 
different types of activity the mechanisms and quantitative importance of each mechanism may 
vary. The reduction in isometric force in fatigue can be divided into three components: 1) 
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reduced maximum isometric force, 2) reduced myofibrillar Ca
2+
 sensitivity, and 3) reduced SR 
Ca
2+
 release (Allen et al., 1995). The major focus for the future should be to identify 
mechanisms that contribute to skeletal muscle fatigue during disease processes. Fatigue is the 
most frequent symptom reported in the primary health care setting (Hickie et al., 1996). This 
occurs when the intended physical activity can no longer be continued or is perceived as 
involving excess effort and discomfort. This is particularly tragic because, often, those patients 
in whom physical activity could be of great therapeutic value (e.g., heart failure and diabetes 
patients) are the least capable of performing such activity. 
 
Patients with CHF frequently report increased fatigue; intuitively one may 
presume that this fatigue is associated with poor cardiac performance and consequently impaired 
muscle O2 delivery. However there is evidence that muscle dysfunction in CHF can be 
demarcated from O2 delivery deficits per se. (Wilson, 1995). This implies that there may be 
crucial peripheral deficits in skeletal muscles in CHF, a conclusion that is supported by 
numerous studies which have reported important functional and biochemical changes in skeletal 
muscle cells in CHF (Harrington & Coats, 1997; Lunde et al., 2001; Nicoletti et al., 2003). 
These changes may affect fatigue development by acting both on myofibrillar function and SR 
Ca
2+
 handling (Lunde et al, 2001; Lunde et al., 2006). 
 
The aim of the current project is to determine the in-vivo efficacy of a calcium 
sensitizing compound using a healthy whole body exercise (running) animal model. The future 
goals of this project would include testing of calcium sensitizing compounds in models of 






























Thirty three male Sprague-Dawley rats (initial age 2-4 months) were obtained from 
Charles River Laboratories (Boston, MA). Upon arrival at Kansas State University, all rats were 
housed two per cage in an Associations for Assessment and Acreditation of Laboratory Animal 
Care (AAALAC) approved facility, maintained on a 12:12 hour light/dark cycle, and provided 
with food and water ad libitum. All experimental procedures were approved by the Kansas State 
University Institutional Animal Care and Use Committee IACUC and performed according to 
the American Physiological Society’s guidelines for animal handling and care. 
Determination of Exercise Tolerance 
 
Each rat was weighed before the initiation of the exercise tolerance protocol for 
determination of exercise endurance. The protocol consisted of a progressive exercise test in 
which each rat initially ran at a speed of 25 m/min up a +10 % grade for 15 min. Thereafter, the 
treadmill speed was increased by 5 m/min every 15 min until the rat could no longer maintain 
pace with the treadmill, despite encouragement to do so by applying manual bursts of high-
pressure air aimed at the hind legs. Immediately after the end of each exercise test, each rat was 
removed from the treadmill and fatigue was confirmed by the loss of the animals’ righting 
reflex. The time-to-fatigue was recorded to the nearest second and each rat was re-weighed upon 
completion of the test. The results reported herein reflect the rats’ post-exercise test weight. Our 
laboratory has previously demonstrated that this protocol results in depletion of muscle glycogen 
stores and therefore elicits a true index of physiological fatigue (Musch et al., 1988; Musch et 
al., 1990). 
 




Each rat was weighed before the initiation of the maximal exercise test for determination
 
  
of VO2peak.  VO2peak was determined according to previously established methods that have been
 
used extensively in our laboratory (Musch et al., 1988; Musch et al., 1988b). This method 
  
employs a metabolic chamber (14.5 x 43 x 7 cm) designed to fit into one stall on the treadmill, 
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and utilizes the standard techniques described by Brooks and White (Brooks & White, 1978) and 
Musch et al. (Musch et al., 1988) for determining O2 and carbon dioxide production (CO2). Gas 
analysis measurements were made via CO2 and O2 (CO2: model CD-3A; O2: model S-3A/I; AEI 
Technologies, Pittsburgh, PA) analyzers set in series. The analyzers were calibrated before and 
after each maximal exercise test using precision-mixed gases that spanned the expected range of 
gas concentrations based on previous investigations. 
 
The maximal exercise test was initiated by having each rat run at 25 m/min up a 10% 
grade for 2-3 minutes which served both as a warm-up and familiarization phase. The speed of 
the treadmill was then increased progressively in a ramp-like manner until the rat could no 
longer keep up with the treadmill speed.  VO2peak was defined as the point at which O2 did not 
further increase despite increases in treadmill speed, or the VO2 at which the rat was no longer 
able/willing to run.  In untrained rats it has  previously been documented that either of these 
criteria produce similar VO2peak values (Bedford et al., 1979).  Each rat was re-weighed upon 
termination of the maximal exercise test, and the results reported herein reflect the rats’ post- 
exercise test weight. We have previously reported qualitatively that determination of VO2peak 
utilizing this protocol is highly reproducible; however, quantitative measures of within-rat 




All rats were familiarized with running on a motor-driven treadmill 5-10 min/day for 5 
days at 25 m/min, +10% grade. Upon familiarization, and within a maximum of 3 days of the 
final acclimatization run, the experimental protocol was initiated in which each rat performed 5 
submaximal endurance runs to fatigue for the determination of exercise tolerance, and 5 
 
maximal exercise tests for determination of VO2peak. No exercise tests, irrespective of nature, 
were completed on successive days. Prior to each run (~2 hours) rats were given a calcium 
sensitizing compound via gastric gavage. Our laboratory is experienced with this technique. 
The rats were divided randomly into three groups, which consisted of control (n=14), a High 
dose group (n=14), which performed each test at 3 different doses (10, 20, and 40 mg/kg), and a 































All data are presented as mean ± SE.  Repeated measures ANOVA was used to 
compare data obtained on the exercise tolerance and VO2peak tests across conditions. Where a 
significant difference was detected, Tukey’s post hoc test was used to determine where the 
differences existed between runs. Pearson correlations were used to assess the possibility of 




























The average initial body weight of the rats was 352 ± 13 g (range 278 – 396 g) and 
increased to 473 ± 10 (range 396-513 g) by the end of the ~6 week experimental protocol. 
 
Measurement of Endurance Exercise Tolerance 
 
The average endurance running time is presented in Figure 1. The dose of 10 mg/kg 
significantly increased (P<0.05) running endurance. This effect was not present at either lower 
(0.5-5 mg/kg) or higher (20-40 mg/kg) doses. Indeed, the very high dose of the calcium 
sensitizing compound (40 mg/kg) had a deleterious effect on exercise performance (P<0.05). 
The individual responses from the high dose group are represented in figure 2. Once again, the 
data indicates a significant increase (P<0.05) in the endurance capacity at 10 mg/kg, and a 
marked decrease (P<0.05) in the endurance capacity at 40 mg/kg. Control group running times 
were not significantly different from each other (P<0.05) 
 
Measurement of VO2peak 
The average VO2peak for all six doses of the calcium sensitizing compound is presented in 
figure 3.  As depicted, the increase in running capacity at 10 mg/kg occurred in the absence of 
any alterations in VO2peak.  The highest dose (40 mg/kg) showed a significant decrease in VO2peak 
(P<0.05) compared to all other doses of the drug, including the control condition. Control Group 

















































70                 
*
   
 
          
 
60
           
 
          
 
50
            
 
               
                  
                
 
              
 
               
 
                
 
               
40
            
** 
 
          
 
           
 
30
           
 
            
 
20
            
 
           
 











Figure 4.1. Endurance running times for all six doses of the calcium sensitizing 
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Figure 4.2. Individual responses from high dose group for endurance running time.  * P<
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Figure 4.3. VO 2peak responses measured at all six doses of the calcium sensitizing 
compound along with VO2peak measured under resting conditions.  Mean ± SE. * P< 0.05 






















CHAPTER 5- Discussion 
 
 
The key finding of this investigation was that acute administration of calcium sensitizing 
compound, at a dose of 10 mg/kg, effectively increased the running endurance in young male 
Sprague-Dawley rats. This effect was not present at either lower (0.5-5 mg/kg) or higher (20-40 
mg/kg) doses. The improvement in running capacity occurred in the absence of any alterations 
in VO2peak. 
 
Putative Mechanism(s) of Action 
 
The physiological mechanism behind how the calcium sensitizing compound used in this 
investigation works remains unknown to our investigative team at this time. However, this 
calcium sensitizing compound is postulated to have a role in increasing Ca
2+
 sensitivity of 
skeletal muscle. A reduction in maximum isometric force is one expression of fatigue. There are 
at least two metabolic changes that contribute to a decline of maximum isometric force: acidosis 
(due to lactic acid accumulation) and accumulation of Pi (due to PCr breakdown). It is well 
established that acidosis and increased Pi reduce the maximum isometric force in both skinned 
and intact muscle fibers (Fabiato & Fabiato, 1978; Sahlin et al., 1989; Westerblad & Allen 1993; 
Pate & Cooke, 1989; Dantzig et al., 1992). Acute administration of the compound used in our 
investigation may have increased cystolic [Ca
2+
] during fatigue. As the muscle becomes more 
fatigued there is a decrease in cystolic [Ca
2+
]. This is partially due to increased Pi, which 
ultimately leads to a decreased Ca
2+
 in the SR ([Ca
2+
]SR). The compound used in our study may 
increase the amount of Ca
2+
 available as the [Ca
2+
 ]SR declines during fatigue perhaps preserving 
function. 
 
The reduction in myofibrillar Ca
2+
 sensitivity associated with fatigue can occur either 
via competition for the Ca
2+
 -binding sites on troponin C or via a reduction in the strength of 










(Blanchard et al., 1984).  The compound used in our study may have increased the amount of 
free [Ca
2+
] and allow more Ca
2+
 to bind to troponin C, and also increased the affinity of 
troponin C for [Ca
2+





 release, caused by a decrease in the cystolic [Ca
2+
]i is the final 
component of the reduction in isometric force. Impaired SR Ca
2+
 release is a well-established 
mechanism of fatigue (Allen et al., 2008; Favero,1999). The combined effects of reduced 
 [Ca
2+
]SR , secondary to CaPi precipitation, the inhibitory effect of high [Mg
2+
]i, and lowered 
[ATP] on the RyR all may contribute to reduced Ca
2+
 release. It also is postulated that there is 
a failure of the AP in the T-tubules (Allen et al., 2008). The compound used in our study may 
work like other agents capable of facilitating SR Ca
2+
 release, such as caffeine, by sensitizing 
the RYR channels to activation of cystolic [Ca
2+
], leading to an increase in the open 
probability (Po) of the channel (Eberstein and Sandow, 1963). 
 
The compound used in our study was able to increase the rats’ endurance capacity in the 
absence of altered VO2peak. Therefore, the increase in endurance capacity was not due to 
changing the exercise intensity domain per se for any given state of the test. 
 
Comparison with Current Literature 
 
The data suggest that a calcium sensitizing compound can improve performance and 
increase exercise tolerance, but only at the specific dose of 10 mg/kg for the compound we used 
in this investigation. Administration of the compound at a dose of 10 mg/kg increased exercise 
tolerance 22% (from 47.54 ± 3.12 min, control – to 58.28 ± 3.30 min, P<0.05). The data also 
suggest that treatment with the compound at high doses (40 mg/kg) may actually be deleterious 
to exercise performance. The findings of this study clearly warrant additional experiments to 
test the efficacy of this compound in animal models of chronic disease (i.e. CHF and diabetes). 
These individuals could benefit from such a calcium sensitizing agent and increase their 
exercise tolerance. This enhanced physical capacity could be of great therapeutic value in 
helping to alleviate symptoms associated with different disease states (i.e. CHF and diabetes). 
 
There is a broad range of strategies available that may improve exercise tolerance, such 
as the administration of sodium bicarbonate (NaHCO3), antioxidant supplementation, 
carbohydrate (CHO) loading, and the ingestion of caffeine. The efficacy of these will be 
considered below. 
The evidence suggesting that NaHCO3 ingestion can be beneficial and may increase 





NaHCO3 increased time-to-fatigue by 4%.  The subjects in the study performed six 60-s cycling 
 
bouts, at a work rate corresponding to 125% VO2peak, with 60 s recovery between work bouts. 
The sixth work bout was continued until the pedal rate dropped below 50 rev min. Another 
study suggested that NaHCO3 could increase mean peak power by 2% (Lavender et al., 1989). 
Subjects in this latter study completed six trials; each trial consisted of 10 ten-second sprints on a 
cycle ergometer with 50 seconds recovery between each sprint. NaHCO3 acts as a buffer to help 
sequester hydrogen ions and forestall the decrement in blood and muscle pH. NaHCO3 binds 
with H
+
 to form carbonic acid, which subsequently dissociates to carbon dioxide (CO2) and 
water (H2O) (Matson et al., 1993). In general, NaHCO3 is thought not to have a major impact on 
endurance performance due to the fact that endurance exercise is supported mostly by oxidative 
 
metabolism.  
The data suggesting that antioxidant supplementation has an effect on exercise 
performance is also varied. It has been demonstrated that antioxidants help protect against the 
effects of exercise-induced muscle damage (Sen, 2001). Kaminiski and Boal (1992) 
demonstrated that antioxidant supplementation reduced muscle soreness by >33%. Schröder et 
al. (2000) observed a decrease of 13.6% in the lipoperoxide levels in athletes who were 
supplemented with a three-compound antioxidant regimen, and an increase in the oxidative 
status. Therefore the question still remains whether individuals need antioxidant supplements to 
prevent oxidative damage from exercise or to help them to recover from that damage. 
The use of caffeine as an ergogenic aid was stimulated by a study examining the effect 
of caffeine ingestion prior to cycling to exhaustion (Costill et al., 1978). The cyclists increased 
their time to exhaustion by 28% (75 min placebo vs. 96 min caffeine ingestion). A second study 
also demonstrated the ergogenic potential of caffeine by increasing the amount of work 
performed in 2 hours of isokinetic cycling exercise (80 rpm) by 20% (Ivy et al., 1979). It has 
also been shown that caffeine can increase lypolysis 23% which may lead to a glycogen sparing 
within the skeletal muscle via stimulating adrenaline secretion which mobilizes free fatty acids 
which in turn causes an increase in fat utilization thereby retarding glycogen depleting (Costill 
et al., 1978). In addition to reducing glycogenolysis caffeine increases [Ca
2+
]i via mobilization 




It now widely accepted that several days of elevated CHO intake following a 
glycogen depleting bout of exercise will super-compensate glycogen levels and help improve 
exercise performance, especially in exercise lasting longer than 90 minutes but, also during 
very high intensity exercise. Diets high in complex or simple CHO have been shown to 
increase running endurance by 23 and 26% (Brewer et al., 1988; Lamb et al., 1991). Another 
study showed that 312 grams of carbohydrate ingested 4 hours prior to moderately intense 
intermittent endurance exercise increased performance by 15% (Sherman et al., 1989). 
The commonality between the nutritional ergogenic aids discussed, and the compound 
used in this study is that they all result in an increase in exercise performance, and some may 
also decrease the damage caused by strenuous exercise, allowing the individual to exercise for 
longer durations at high intensity.  The calcium sensitizing compound used in this study was 
able to increase endurance tolerance by 22%. This value is impressive when compared to other 
so-called ergogenic aids evaluated in the scientific literature, and reinforces the therapeutic 
potential that calcium sensitizing agents may have for individuals with chronic disease (i.e. 
CHF and diabetes). 
Methodological Considerations 
In the rat, a broad range of treadmill running protocols exists for submaximal exercise 
endurance tests. It is surprising, therefore, that no rigorous analysis of exercise performance 
reproducibility has been performed in the rat, particularly considering the diversity of protocols, 
equipment, and running technique employed in different laboratories (Bedford et al.,1979; Musch 
et al., 1988; Hilty et al., 1989; Dubouchaud et al.,1999; Kim et al., 2003; Georgieva & Boyadjiev, 
2004). The design of the treadmill protocol in the present investigation ensured that fatigue 
occurred within a reasonable time and maximizes both aerobic and so-called anaerobic energy 
systems. Using the present protocol Copp et al. (2009) demonstrated that, over time, exercise 
tolerance and VO2peak are highly reproducible with repeated testing coefficients of variation < 
10%. In this regard, important considerations for experimental design include the introduction 
of increasing variability as more exercise tolerance test are performed. In addition, there is the 
potential for confounding influence of increases in body mass during the experimental protocol 
that might affect VO2peak. However, our results and our experimental design provide confidence 





As stated earlier, there are many ergogenic aids directed towards athletes and “weekend 
warriors” that can potentially improve exercise performance. What is less appreciated is that 
individuals who suffer from chronic diseases (i.e. CHF, and diabetes) can also benefit greatly 
 
from the administration of ergogenic aids to improve exercise performance, and their quality of 
life. In the case of CHF, most pharmacological interventions have been aimed at improving 
some of the central components to offset fatigue, for example enhancing heart function and 
reducing the increase in sympathetic system stimulation. A novel approach to combat CHF may 
be to target the periphery (i.e. muscle) and reverse the pathologic changes in the skeletal muscle 
itself possibly through the administration of calcium sensitizing compounds. 
 
The compound used in this study was able to significantly increase endurance capacity of  
 
normal rats at a dose of 10 mg/kg. Indeed, this improvement was not accompanied with 
increases in VO2peak. Further studies need to be conducted to explore the efficacy of this 
compound in animal models of chronic disease (i.e. CHF and diabetes). The compound used in 
our investigation may potentially be an ergogenic aid for patients whom enhanced physical 
capacity could be of great therapeutic value, and lead to increases in activities of daily living and 
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